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Summary: This study illustrates that a higher ratio of surgical treated 
stage I patients in Niigata Prefecture. Adenocarcinoma was the most 
frequent histology. These updated data may predict future strategy for 
preventing and treating lung cancer. Follow-up study to determine the 
5-year survival should be scheduled.
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Patients with cancer have an increased risk of thromboembolism which 
leads to additional morbidity and mortality, also reduces the quality of 
life. Hypercoagulation is the most important cause of thromboembo-
lism in malignancy. Extended immobilization, operations and executed 
chemotherapy are the other risk factors for thromboembolism in cancer 
patients. 
202 patients had been hospitalized in our clinic with the diagnosis of 
malignancy in 2006; 188 patients had the diagnosis of lung cancer in 
this group. The patients who had the complaints like sudden dyspnea, 
tachypnea, chest pain were evaluated for pulmonary thromboembo-
lism when venous thrombosis was investigated if there were physical 
ﬁndings such as swelling, pain, erythema and warmth of extremities. 
The investigated patients with the possible diagnosis of thromboem-
bolism did not have any other risk factors for this disease; the only 
risk factor was malignancy. Spiral computed tomography or venous 
Doppler ultrasonography were performed to demonstrate thromboem-
bolism at these patients. Thrombosis or embolism were determined in 
34 of all cancer patients (16.8 %) when the number of new diagnosis 
of thromboembolism was 27 in 188 lung cancer patients (14.4 %). The 
mean age was 62,1 and thromboembolism was found in 23 men (67.7 
%) and 11 women (32.3 %). In the patients with lung cancer, there were 
12 patients with pulmonary thromboembolism, 8 with venous thrombo-
sis, 6 with superior vena cava syndrome and one patient with brachial 
artery embolism. All of the lung cancer patients with thromboembolism 
had NSCLC; 11 of them had adenocarcinoma, 5 had squamous cell 
lung carcinoma and in 11 patients, there was no certain histopathologi-
cal type of NSCLC. There were 85 patients who had the diagnosis of 
thromboembolism in our clinic in 2006; malignancy was the only main 
risk factor for VTE in 34 patients (40 %) and the existence of lung 
cancer was 31.7 % in all thromboembolism patients.
Malignancy, mostly the lung cancer, is one of the most important 
acquired medical predispositions for thromboembolism. Furthermore, 
it should not be forgotten that thromboembolism is seen with a high 
frequency in lung cancer patients.
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To evaluate the surgical skills in pleuro-pneumonectomy of lung 
cancer with effusion and the effect of the operation, from Jan.1988 
to Jan.2003, 21 patients of primary lung cancer with dissemination 
and malignant pleural effusion were treated chieﬂy by operation. The 
surgical procedures included left pleuro-pneumonectomy in 8 and right 
pleuro-pneumonectomy in 13 patients. The operative skills include 
plural dissection en bloc, management of big vessel in hilar, paying 
attention to disposal of dissemination on pericardium, big vessels and 
diaphragm, etc. All patients recovered postoperatively. There were no 
severe surgical complications such as bronchopleural ﬁstula, empyema 
and hemorrhage. Follow-up showed that 16 patients have died at 5 to 
34 months after the operation. Other patients were still alive at 24 to 29 
months. Mid-lifetime was 18 months. Pleuro-pneumonectomy selec-
tively performed in lung cancer with malignant pleural effusion (IIIb) is 
safe and manipulatable. Improvement of the surgical skills may reduce 
the perioperative complications, decrease recurrence of the tumor and 
so gain a better result.
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Objectives: The incidence of lung cancer associated with interstitial 
pneumonia (IP) is higher than that of general population. However, 
treatment of that cancer is difﬁcult because of the risk of acute exacer-
bation of IP. We studied safety and efﬁcacy of surgical treatment in 10 
cases of IP associated lung cancers.
Patients and methods: Ten cases of IP associated lung cancers were 
selected from the 462 cases that underwent surgical operation for pri-
mary lung cancer from 1999 to 2006. Incidence of IP associated cancer 
was 2.16%. All patients were male and average age was 70.5 years 
old (range 56 to 80 years old). Histo-pathological diagnosis of IP was 
UIP (Usual Interstitial Pneumonia) in eight cases and f-NSIP (Fibrotic 
Nonspeciﬁc Interstitial Pneumonia) in two cases.
Result: Lobectomy was performed in seven cases. Six of them 
underwent standard radical lobectomy with mediastinal lymph node 
dissection. Procedures were reduced to segmentectomy in two cases 
and not successful in one case. Histological diagnosis was squamous 
cell carcinoma in 9 cases except one patient who was diagnosed as 
unclassiﬁed carcinoma. Acute exacerbation of IP was observed in only 
one case. The other patients discharged well without any complications. 
Acute exacerbation of IP was responded well to steroid pulse therapy 
and improved. Median survival time of the studied cases was 17.6 
months. Three cases died from exacerbation of interstitial pneumonia, 
and another two cases are still alive. No cancer death was observed in 
the six cases with radical lobectomy group.
Conclusions: Survival outcome of IP associated lung cancer was not 
good. But there was no surgery-associated death and acute exacerbation 
of IP was controllable. Surgical treatment was acceptable and feasible 
therapy for the patients with IP associated lung cancer.
